img

Global Antiemetic Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antiemetic Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
Antiemetic Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antiemetic Drugs market is projected to reach US$ 6489.9 million in 2034, increasing from US$ 4755.6 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2034. Demand from Chemotherapy and Gastroenteritis are the major drivers for the industry.
The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of the acquiring vendor.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antiemetic Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Segment by Type
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist

Segment by Application


Chemotherapy
Gastroenteritis
Surgery

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antiemetic Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antiemetic Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antiemetic Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Antiemetic Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antiemetic Drugs introduction, etc. Antiemetic Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Antiemetic Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Antiemetic Drugs Market Overview
1.1 Antiemetic Drugs Product Overview
1.2 Antiemetic Drugs Market Segment by Type
1.2.1 Dopamine Antagonist
1.2.2 5-HT-3 Receptor Antagonist
1.2.3 NK1 Receptor Antagonist
1.2.4 Cannabinoid Receptor Antagonist
1.3 Global Antiemetic Drugs Market Size by Type
1.3.1 Global Antiemetic Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Antiemetic Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Antiemetic Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antiemetic Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Antiemetic Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Antiemetic Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Antiemetic Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Antiemetic Drugs Sales Breakdown by Type (2024-2024)
2 Global Antiemetic Drugs Market Competition by Company
2.1 Global Top Players by Antiemetic Drugs Sales (2024-2024)
2.2 Global Top Players by Antiemetic Drugs Revenue (2024-2024)
2.3 Global Top Players by Antiemetic Drugs Price (2024-2024)
2.4 Global Top Manufacturers Antiemetic Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antiemetic Drugs Market Competitive Situation and Trends
2.5.1 Antiemetic Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antiemetic Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Antiemetic Drugs Market
2.8 Key Manufacturers Antiemetic Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antiemetic Drugs Status and Outlook by Region
3.1 Global Antiemetic Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Antiemetic Drugs Historic Market Size by Region
3.2.1 Global Antiemetic Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Antiemetic Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Antiemetic Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Antiemetic Drugs Forecasted Market Size by Region
3.3.1 Global Antiemetic Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Antiemetic Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Antiemetic Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antiemetic Drugs by Application
4.1 Antiemetic Drugs Market Segment by Application
4.1.1 Chemotherapy
4.1.2 Gastroenteritis
4.1.3 Surgery
4.2 Global Antiemetic Drugs Market Size by Application
4.2.1 Global Antiemetic Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Antiemetic Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Antiemetic Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antiemetic Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Antiemetic Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Antiemetic Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Antiemetic Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Antiemetic Drugs Sales Breakdown by Application (2024-2024)
5 North America Antiemetic Drugs by Country
5.1 North America Antiemetic Drugs Historic Market Size by Country
5.1.1 North America Antiemetic Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Antiemetic Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Antiemetic Drugs Sales in Value by Country (2024-2024)
5.2 North America Antiemetic Drugs Forecasted Market Size by Country
5.2.1 North America Antiemetic Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Antiemetic Drugs Sales in Value by Country (2024-2034)
6 Europe Antiemetic Drugs by Country
6.1 Europe Antiemetic Drugs Historic Market Size by Country
6.1.1 Europe Antiemetic Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Antiemetic Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Antiemetic Drugs Sales in Value by Country (2024-2024)
6.2 Europe Antiemetic Drugs Forecasted Market Size by Country
6.2.1 Europe Antiemetic Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Antiemetic Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Antiemetic Drugs by Region
7.1 Asia-Pacific Antiemetic Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Antiemetic Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Antiemetic Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Antiemetic Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Antiemetic Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Antiemetic Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antiemetic Drugs Sales in Value by Region (2024-2034)
8 Latin America Antiemetic Drugs by Country
8.1 Latin America Antiemetic Drugs Historic Market Size by Country
8.1.1 Latin America Antiemetic Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Antiemetic Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Antiemetic Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Antiemetic Drugs Forecasted Market Size by Country
8.2.1 Latin America Antiemetic Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antiemetic Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Antiemetic Drugs by Country
9.1 Middle East and Africa Antiemetic Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Antiemetic Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Antiemetic Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Antiemetic Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Antiemetic Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Antiemetic Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antiemetic Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 GlaxoSmithKline Antiemetic Drugs Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Johnson & Johnson Antiemetic Drugs Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Pfizer Antiemetic Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Sanofi Antiemetic Drugs Products Offered
10.4.5 Sanofi Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Abbott Antiemetic Drugs Products Offered
10.5.5 Abbott Recent Development
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Company Information
10.6.2 Bristol-Myers Squibb Introduction and Business Overview
10.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Bristol-Myers Squibb Antiemetic Drugs Products Offered
10.6.5 Bristol-Myers Squibb Recent Development
10.7 Cipla
10.7.1 Cipla Company Information
10.7.2 Cipla Introduction and Business Overview
10.7.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Cipla Antiemetic Drugs Products Offered
10.7.5 Cipla Recent Development
10.8 Eisai
10.8.1 Eisai Company Information
10.8.2 Eisai Introduction and Business Overview
10.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Eisai Antiemetic Drugs Products Offered
10.8.5 Eisai Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Eli Lilly Antiemetic Drugs Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Glenmark
10.10.1 Glenmark Company Information
10.10.2 Glenmark Introduction and Business Overview
10.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Glenmark Antiemetic Drugs Products Offered
10.10.5 Glenmark Recent Development
10.11 Helsinn Healthcare
10.11.1 Helsinn Healthcare Company Information
10.11.2 Helsinn Healthcare Introduction and Business Overview
10.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Helsinn Healthcare Antiemetic Drugs Products Offered
10.11.5 Helsinn Healthcare Recent Development
10.12 Heron Therapeutics
10.12.1 Heron Therapeutics Company Information
10.12.2 Heron Therapeutics Introduction and Business Overview
10.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Heron Therapeutics Antiemetic Drugs Products Offered
10.12.5 Heron Therapeutics Recent Development
10.13 IPCA Laboratories
10.13.1 IPCA Laboratories Company Information
10.13.2 IPCA Laboratories Introduction and Business Overview
10.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.13.4 IPCA Laboratories Antiemetic Drugs Products Offered
10.13.5 IPCA Laboratories Recent Development
10.14 Lupin
10.14.1 Lupin Company Information
10.14.2 Lupin Introduction and Business Overview
10.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Lupin Antiemetic Drugs Products Offered
10.14.5 Lupin Recent Development
10.15 Merck
10.15.1 Merck Company Information
10.15.2 Merck Introduction and Business Overview
10.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Merck Antiemetic Drugs Products Offered
10.15.5 Merck Recent Development
10.16 Novartis
10.16.1 Novartis Company Information
10.16.2 Novartis Introduction and Business Overview
10.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Novartis Antiemetic Drugs Products Offered
10.16.5 Novartis Recent Development
10.17 RedHill
10.17.1 RedHill Company Information
10.17.2 RedHill Introduction and Business Overview
10.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.17.4 RedHill Antiemetic Drugs Products Offered
10.17.5 RedHill Recent Development
10.18 Sun Pharmaceutical Industries
10.18.1 Sun Pharmaceutical Industries Company Information
10.18.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Products Offered
10.18.5 Sun Pharmaceutical Industries Recent Development
10.19 Takeda Pharmaceutical
10.19.1 Takeda Pharmaceutical Company Information
10.19.2 Takeda Pharmaceutical Introduction and Business Overview
10.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Takeda Pharmaceutical Antiemetic Drugs Products Offered
10.19.5 Takeda Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antiemetic Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antiemetic Drugs Industrial Chain Analysis
11.4 Antiemetic Drugs Market Dynamics
11.4.1 Antiemetic Drugs Industry Trends
11.4.2 Antiemetic Drugs Market Drivers
11.4.3 Antiemetic Drugs Market Challenges
11.4.4 Antiemetic Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antiemetic Drugs Distributors
12.3 Antiemetic Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Dopamine Antagonist
Table 2. Major Company of 5-HT-3 Receptor Antagonist
Table 3. Major Company of NK1 Receptor Antagonist
Table 4. Major Company of Cannabinoid Receptor Antagonist
Table 5. Global Antiemetic Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Antiemetic Drugs Sales by Type (2024-2024) & (K Units)
Table 7. Global Antiemetic Drugs Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Antiemetic Drugs Sales by Type (2024-2024) & (US& Million)
Table 9. Global Antiemetic Drugs Market Share in Value by Type (2024-2024)
Table 10. Global Antiemetic Drugs Price by Type (2024-2024) & (USD/Unit)
Table 11. Global Antiemetic Drugs Sales by Type (2024-2034) & (K Units)
Table 12. Global Antiemetic Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Antiemetic Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Antiemetic Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Antiemetic Drugs Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Antiemetic Drugs Sales by Type (2024-2024) & (K Units)
Table 17. North America Antiemetic Drugs Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Antiemetic Drugs Sales (K Units) by Type (2024-2024)
Table 19. Europe Antiemetic Drugs Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Antiemetic Drugs Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Antiemetic Drugs Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Antiemetic Drugs Sales (K Units) by Type (2024-2024)
Table 23. Latin America Antiemetic Drugs Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Antiemetic Drugs Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Antiemetic Drugs Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Antiemetic Drugs Sales by Company (2024-2024) & (K Units)
Table 27. Global Antiemetic Drugs Sales Share by Company (2024-2024)
Table 28. Global Antiemetic Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Antiemetic Drugs Revenue Share by Company (2024-2024)
Table 30. Global Market Antiemetic Drugs Price by Company (2024-2024) & (USD/Unit)
Table 31. Global Antiemetic Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Antiemetic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Antiemetic Drugs Market
Table 35. Key Manufacturers Antiemetic Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Antiemetic Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Antiemetic Drugs Sales by Region (2024-2024) & (K Units)
Table 39. Global Antiemetic Drugs Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Antiemetic Drugs Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Antiemetic Drugs Sales Market Share in Value by Region (2024-2024)
Table 42. Global Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 43. Global Antiemetic Drugs Sales by Region (2024-2034) & (K Units)
Table 44. Global Antiemetic Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Antiemetic Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Antiemetic Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Antiemetic Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Antiemetic Drugs Sales by Application (2024-2024) & (K Units)
Table 50. Global Antiemetic Drugs Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Antiemetic Drugs Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Antiemetic Drugs Sales Market Share in Value by Application (2024-2024)
Table 53. Global Antiemetic Drugs Price by Application (2024-2024) & (USD/Unit)
Table 54. Global Antiemetic Drugs Sales by Application (2024-2034) & (K Units)
Table 55. Global Antiemetic Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Antiemetic Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Antiemetic Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global Antiemetic Drugs Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Antiemetic Drugs Sales by Application (2024-2024) (K Units)
Table 60. North America Antiemetic Drugs Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Antiemetic Drugs Sales by Application (2024-2024) (K Units)
Table 62. Europe Antiemetic Drugs Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Antiemetic Drugs Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Antiemetic Drugs Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Antiemetic Drugs Sales by Application (2024-2024) (K Units)
Table 66. Latin America Antiemetic Drugs Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Antiemetic Drugs Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Antiemetic Drugs Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Antiemetic Drugs Sales by Country (2024-2024) & (K Units)
Table 70. North America Antiemetic Drugs Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Antiemetic Drugs Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Antiemetic Drugs Sales Market Share in Value by Country (2024-2024)
Table 73. North America Antiemetic Drugs Sales by Country (2024-2034) & (K Units)
Table 74. North America Antiemetic Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Antiemetic Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Antiemetic Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Antiemetic Drugs Sales by Country (2024-2024) & (K Units)
Table 78. Europe Antiemetic Drugs Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Antiemetic Drugs Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Antiemetic Drugs Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Antiemetic Drugs Sales by Country (2024-2034) & (K Units)
Table 82. Europe Antiemetic Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Antiemetic Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Antiemetic Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Antiemetic Drugs Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Antiemetic Drugs Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Antiemetic Drugs Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Antiemetic Drugs Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Antiemetic Drugs Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Antiemetic Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Antiemetic Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Antiemetic Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Antiemetic Drugs Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Antiemetic Drugs Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Antiemetic Drugs Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Antiemetic Drugs Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Antiemetic Drugs Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Antiemetic Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Antiemetic Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Antiemetic Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Antiemetic Drugs Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Antiemetic Drugs Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Antiemetic Drugs Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Antiemetic Drugs Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Antiemetic Drugs Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Antiemetic Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Antiemetic Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Antiemetic Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. GlaxoSmithKline Company Information
Table 110. GlaxoSmithKline Introduction and Business Overview
Table 111. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 112. GlaxoSmithKline Antiemetic Drugs Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Johnson & Johnson Company Information
Table 115. Johnson & Johnson Introduction and Business Overview
Table 116. Johnson & Johnson Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 117. Johnson & Johnson Antiemetic Drugs Product
Table 118. Johnson & Johnson Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 122. Pfizer Antiemetic Drugs Product
Table 123. Pfizer Recent Development
Table 124. Sanofi Company Information
Table 125. Sanofi Introduction and Business Overview
Table 126. Sanofi Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 127. Sanofi Antiemetic Drugs Product
Table 128. Sanofi Recent Development
Table 129. Abbott Company Information
Table 130. Abbott Introduction and Business Overview
Table 131. Abbott Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 132. Abbott Antiemetic Drugs Product
Table 133. Abbott Recent Development
Table 134. Bristol-Myers Squibb Company Information
Table 135. Bristol-Myers Squibb Introduction and Business Overview
Table 136. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 137. Bristol-Myers Squibb Antiemetic Drugs Product
Table 138. Bristol-Myers Squibb Recent Development
Table 139. Cipla Company Information
Table 140. Cipla Introduction and Business Overview
Table 141. Cipla Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 142. Cipla Antiemetic Drugs Product
Table 143. Cipla Recent Development
Table 144. Eisai Company Information
Table 145. Eisai Introduction and Business Overview
Table 146. Eisai Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 147. Eisai Antiemetic Drugs Product
Table 148. Eisai Recent Development
Table 149. Eli Lilly Company Information
Table 150. Eli Lilly Introduction and Business Overview
Table 151. Eli Lilly Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 152. Eli Lilly Antiemetic Drugs Product
Table 153. Eli Lilly Recent Development
Table 154. Glenmark Company Information
Table 155. Glenmark Introduction and Business Overview
Table 156. Glenmark Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 157. Glenmark Antiemetic Drugs Product
Table 158. Glenmark Recent Development
Table 159. Helsinn Healthcare Company Information
Table 160. Helsinn Healthcare Introduction and Business Overview
Table 161. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 162. Helsinn Healthcare Antiemetic Drugs Product
Table 163. Helsinn Healthcare Recent Development
Table 164. Heron Therapeutics Company Information
Table 165. Heron Therapeutics Introduction and Business Overview
Table 166. Heron Therapeutics Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 167. Heron Therapeutics Antiemetic Drugs Product
Table 168. Heron Therapeutics Recent Development
Table 169. IPCA Laboratories Company Information
Table 170. IPCA Laboratories Introduction and Business Overview
Table 171. IPCA Laboratories Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 172. IPCA Laboratories Antiemetic Drugs Product
Table 173. IPCA Laboratories Recent Development
Table 174. Lupin Company Information
Table 175. Lupin Introduction and Business Overview
Table 176. Lupin Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 177. Lupin Antiemetic Drugs Product
Table 178. Lupin Recent Development
Table 179. Merck Company Information
Table 180. Merck Introduction and Business Overview
Table 181. Merck Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 182. Merck Antiemetic Drugs Product
Table 183. Merck Recent Development
Table 184. Novartis Company Information
Table 185. Novartis Introduction and Business Overview
Table 186. Novartis Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 187. Novartis Antiemetic Drugs Product
Table 188. Novartis Recent Development
Table 189. RedHill Company Information
Table 190. RedHill Introduction and Business Overview
Table 191. RedHill Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 192. RedHill Antiemetic Drugs Product
Table 193. RedHill Recent Development
Table 194. Sun Pharmaceutical Industries Company Information
Table 195. Sun Pharmaceutical Industries Introduction and Business Overview
Table 196. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 197. Sun Pharmaceutical Industries Antiemetic Drugs Product
Table 198. Sun Pharmaceutical Industries Recent Development
Table 199. Takeda Pharmaceutical Company Information
Table 200. Takeda Pharmaceutical Introduction and Business Overview
Table 201. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 202. Takeda Pharmaceutical Antiemetic Drugs Product
Table 203. Takeda Pharmaceutical Recent Development
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Antiemetic Drugs Market Trends
Table 207. Antiemetic Drugs Market Drivers
Table 208. Antiemetic Drugs Market Challenges
Table 209. Antiemetic Drugs Market Restraints
Table 210. Antiemetic Drugs Distributors List
Table 211. Antiemetic Drugs Downstream Customers
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiemetic Drugs Product Picture
Figure 2. Global Antiemetic Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antiemetic Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Antiemetic Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Dopamine Antagonist
Figure 6. Global Dopamine Antagonist Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of 5-HT-3 Receptor Antagonist
Figure 8. Global 5-HT-3 Receptor Antagonist Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of NK1 Receptor Antagonist
Figure 10. Global NK1 Receptor Antagonist Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Cannabinoid Receptor Antagonist
Figure 12. Global Cannabinoid Receptor Antagonist Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Antiemetic Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Antiemetic Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Antiemetic Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Antiemetic Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Antiemetic Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Antiemetic Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Antiemetic Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Antiemetic Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Antiemetic Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Antiemetic Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Antiemetic Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Antiemetic Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiemetic Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiemetic Drugs Revenue in 2022
Figure 27. Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Chemotherapy
Figure 29. Global Chemotherapy Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Gastroenteritis
Figure 31. Global Gastroenteritis Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Surgery
Figure 33. Global Surgery Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Antiemetic Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Antiemetic Drugs Sales Market Share by Application in 2022 & 2034
Figure 36. North America Antiemetic Drugs Sales Market Share in Volume by Application in 2022
Figure 37. North America Antiemetic Drugs Sales Market Share in Value by Application in 2022
Figure 38. Europe Antiemetic Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Europe Antiemetic Drugs Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Antiemetic Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Antiemetic Drugs Sales Market Share in Value by Application in 2022
Figure 42. Latin America Antiemetic Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Antiemetic Drugs Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Antiemetic Drugs Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Antiemetic Drugs Manufacturing Cost Structure
Figure 47. Antiemetic Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed